Program overview
Context
Indication: Early Breast Cancer (Phase 2)
Mechanism: Unknown
Modality: Unknown
Sponsor: Pfizer
PF-04691502 is flagged as registry stop signal because public records show a registry stop signal. This is a public-data monitoring signal, not a conclusion about clinical failure, regulatory noncompliance, or sponsor intent.
Indication: Early Breast Cancer (Phase 2)
Mechanism: Unknown
Modality: Unknown
Sponsor: Pfizer
Registry: 5/5
Timeline: 1/5
Recruitment burden: 0/5
Results availability: 0/5
Program risk: 3/5
https://clinicaltrials.gov/study/NCT01430585
| Trial | Status | Timeline | Results | Burden |
|---|---|---|---|---|
| NCT01430585 | Registry Stop Signal (TERMINATED) | stale_update_signal | Low Signal | None |